" /> " />

ANI Pharmaceuticals Earnings Estimate

ANIP Stock  USD 69.69  0.14  0.20%   
The next projected EPS of ANI Pharmaceuticals is estimated to be 0.98 with future projections ranging from a low of 0.88 to a high of 1.06. ANI Pharmaceuticals' most recent 12-month trailing earnings per share (EPS TTM) is at 0.85. Please be aware that the consensus of earnings estimates for ANI Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
ANI Pharmaceuticals is projected to generate 0.98 in earnings per share on the 31st of March 2024. ANI Pharmaceuticals earnings estimates module stress-tests analyst consensus about projected ANI Pharmaceuticals EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as ANI Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing ANI Pharmaceuticals' earnings estimates, investors can diagnose different trends across ANI Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. As of 03/28/2024, Gross Profit is likely to grow to about 257.8 M. Also, Pretax Profit Margin is likely to grow to 0.04
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

ANI Pharmaceuticals Earnings Estimation Breakdown

The calculation of ANI Pharmaceuticals' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ANI Pharmaceuticals is estimated to be 0.98 with the future projection ranging from a low of 0.88 to a high of 1.06. Please be aware that this consensus of annual earnings estimates for ANI Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
1.0
0.88
Lowest
Expected EPS
0.98
1.06
Highest

ANI Pharmaceuticals Earnings Projection Consensus

Suppose the current estimates of ANI Pharmaceuticals' value are higher than the current market price of the ANI Pharmaceuticals stock. In this case, investors may conclude that ANI Pharmaceuticals is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ANI Pharmaceuticals' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2024Current EPS (TTM)
362.86%
1.0
0.98
0.85

ANI Pharmaceuticals Earnings per Share Projection vs Actual

Actual Earning per Share of ANI Pharmaceuticals refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ANI Pharmaceuticals predict the company's earnings will be in the future. The higher the earnings per share of ANI Pharmaceuticals, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

ANI Pharmaceuticals Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as ANI Pharmaceuticals, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ANI Pharmaceuticals should always be considered in relation to other companies to make a more educated investment decision.

ANI Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact ANI Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-29
2023-12-310.861.00.1416 
2023-11-08
2023-09-300.841.270.4351 
2023-08-09
2023-06-300.681.280.688 
2023-05-08
2023-03-310.351.170.82234 
2023-03-09
2022-12-310.670.760.0913 
2022-11-09
2022-09-300.550.640.0916 
2022-08-08
2022-06-300.220.13-0.0940 
2022-05-10
2022-03-310.09-0.12-0.21233 
2022-03-15
2021-12-310.740.54-0.227 
2021-11-01
2021-09-300.71.010.3144 
2021-08-06
2021-06-300.690.67-0.02
2021-05-07
2021-03-310.711.040.3346 
2021-03-09
2020-12-310.940.8-0.1414 
2020-11-05
2020-09-300.880.970.0910 
2020-08-06
2020-06-300.850.69-0.1618 
2020-05-07
2020-03-310.891.040.1516 
2020-02-27
2019-12-311.181.08-0.1
2019-11-06
2019-09-301.431.23-0.213 
2019-08-07
2019-06-301.291.440.1511 
2019-05-09
2019-03-311.051.30.2523 
2019-02-27
2018-12-311.241.320.08
2018-11-06
2018-09-301.171.290.1210 
2018-08-07
2018-06-301.341.13-0.2115 
2018-05-08
2018-03-311.271.320.05
2018-02-27
2017-12-311.071.080.01
2017-11-02
2017-09-300.991.110.1212 
2017-08-03
2017-06-300.860.980.1213 
2017-05-04
2017-03-310.770.74-0.03
2017-03-02
2016-12-311.090.84-0.2522 
2016-11-03
2016-09-301.081.090.01
2016-08-04
2016-06-300.771.110.3444 
2016-05-05
2016-03-310.640.760.1218 
2016-02-23
2015-12-310.60.52-0.0813 
2015-11-03
2015-09-300.560.80.2442 
2015-08-04
2015-06-300.540.550.01
2015-05-05
2015-03-310.560.52-0.04
2015-02-19
2014-12-310.590.42-0.1728 
2014-11-03
2014-09-300.460.660.243 
2014-08-04
2014-06-30-0.01-0.21-0.22000 
2014-05-05
2014-03-310.320.330.01
2014-02-18
2013-12-310.240.410.1770 
2013-11-04
2013-09-300.320.360.0412 
2012-11-08
2012-09-30-1.8-1.620.1810 
2012-08-01
2012-06-30-2.46-2.160.312 
2012-05-08
2012-03-31-1.98-3.24-1.2663 
2012-03-13
2011-12-31-4.05-2.161.8946 
2011-11-09
2011-09-30-5.1-4.320.7815 
2011-07-25
2011-06-30-6.48-5.760.7211 
2011-05-10
2011-03-31-5.18-7.2-2.0238 
2011-03-16
2010-12-31-5.31-6.48-1.1722 
2010-11-12
2010-09-30-5.04-5.76-0.7214 
2010-08-12
2010-06-30-3.78-6.12-2.3461 
2010-05-14
2010-03-31-3.78-6.84-3.0680 
2010-03-30
2009-12-31-3.96-31.32-27.36690 
2009-11-09
2009-09-30-5.76-7.56-1.831 
2009-08-07
2009-06-30-5.4-6.12-0.7213 
2009-05-11
2009-03-31-5.76-5.40.36
2009-03-16
2008-12-31-8.64-1.86.8479 
2008-11-10
2008-09-30-7.2-8.64-1.4420 
2008-08-11
2008-06-30-5.76-7.92-2.1637 
2008-05-09
2008-03-31-3.6-4.68-1.0830 
2008-03-17
2007-12-31-2.88-2.160.7225 
2007-11-13
2007-09-30-3.69-2.161.5341 
2007-08-14
2007-06-30-3.24-3.6-0.3611 
2007-05-01
2007-03-31-2.88-2.880.0
2007-03-08
2006-12-31-2.8815.8418.72650 
2006-11-14
2006-09-30-4.14-1.083.0673 
2006-08-14
2006-06-30-5.22-3.961.2624 
2006-05-12
2006-03-31-6.48-6.120.36
2006-03-31
2005-12-31-4.41-4.68-0.27
2005-11-10
2005-09-30-4.86-3.61.2625 
2005-08-12
2005-06-30-5.4-4.680.7213 
2005-05-13
2005-03-31-5.22-5.040.18
2005-02-15
2004-12-31-6.3-7.92-1.6225 
2004-11-12
2004-09-30-5.76-5.760.0
2004-05-17
2004-03-31-4.32-6.12-1.841 

About ANI Pharmaceuticals Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of ANI Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current ANI Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as ANI Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2024
Retained Earnings-80.1 M-84.1 M
Retained Earnings Total Equity-111.9 M-117.5 M
Price Earnings Ratio 52.86  55.50 
Price Earnings To Growth Ratio(0.40)(0.38)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ANI Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ANI Pharmaceuticals' short interest history, or implied volatility extrapolated from ANI Pharmaceuticals options trading.

Pair Trading with ANI Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with ANI Stock

  0.7MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.79EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against ANI Stock

  0.94KA Kineta Inc Report 29th of March 2024 PairCorr
  0.77MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.73MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.72MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.71MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ANI Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ANI Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ani Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Ani Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for ANI Stock analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is ANI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Earnings Share
0.85
Revenue Per Share
27.044
Quarterly Revenue Growth
0.397
Return On Assets
0.0372
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.